Xenacare Holdings Inc.(fka XCHO)

[sts66]

NPHC finally files 2011 10-K

http://www.sec.gov/Archives/edgar/data/1119643/000114420412061035/v327878_10k.htm

Not making any money selling Nyloxin or Cobroxin:

From October 2009 until December 31, 2011, our operations have centered on the marketing of Cobroxin® and Nyloxin™ and Nyloxin™ Extra Strength, from which we have earned accumulated net revenues of $2,055,882, which includes a reduction of $503,958 for Nyloxin™ sold during 2011 and returned in 2012. During fiscal year 2011, we earned revenues of $79,077 from the sale of Cobroxin® and net revenues of $66,567 from sales of Nyloxin™. Total product sales for fiscal year 2011 were $145,644, net of a reduction of $503,958.

Answer to why I can still buy Cobroxin online - XCHO hasn't sold their original $1M worth of inventory:

In November 2009, XenaCare began selling Cobroxin to brick-and-mortar retailers, including distribution to CVS in March 2010 and Walgreens in May 2010. On April 1, 2011, we notified our Cobroxin Distributor, XenaCare that they were in breach of our agreement. As a result of this, the distribution agreement was terminated effective April 10, 2011. XenaCare had a large stock of the product that they had ordered from us and we have allowed them to continue to market their existing inventory of Cobroxin. In October, 2011 we discontinued their website at www.Cobroxin.com. All current traffic to that website is now redirected to www.Nyloxin.com. We plan to begin manufacturing, marketing and distributing Cobroxin again when funding is available.